Niacinamide

Niacinamide

SCHEMBL8510801

NC(=O)c1cccnc1.NCCCCCCNc1nc2c(N)ncnc2[nH]1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ F7 P08709 1/20 0.42
▸ F3 P13726 1/20 0.42
▸ SARM1 Q6SZW1 1/20 0.42
▸ SIRT2 Q8IXJ6 1/20 0.42
▸ SIRT6 Q8N6T7 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ SIRT3 Q9NTG7 1/20 0.42
▸ SIRT5 Q9NXA8 1/20 0.42
▸ SIRT4 Q9Y6E7 1/20 0.42
▸ CYP3A4 P08684 1/20 0.38
▸ ABL1 P00519 1/20 0.37
▸ BCR P11274 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ PIM1 P11309 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacinamide SCHEMBL8510810 0.90 PI4KA (0.44) EGFRSRCKDRF7F3
SCHEMBL7598522 0.81 PIM1 (0.50) HSP90AA1HSP90AB1PIM1ALDH1A1CHEK1
Niacinamide SCHEMBL8508202 0.79 F7 (0.55) EGFRSRCKDRF7F3
Niacinamide SCHEMBL3281888 0.77 F7 (0.52) EGFRSRCKDRF7F3
SCHEMBL10870632 0.76 HDAC1 (0.49) EGFRSRCKDRCYP3A4PIM1
Spermidine SCHEMBL25434620 0.73 F7 (0.63) F7F3SARM1SIRT2SIRT6
Adenine SCHEMBL11807677 0.72 F7 (0.55) EGFRSRCKDRF7F3
SCHEMBL986023 0.72 CYP2C19 (0.56) CYP3A4MEN1ALDH1A1HTTKMT2A
Niacinamide SCHEMBL8510793 0.72 APEX1 (0.52) EGFRSRCKDRF7F3
Adenine SCHEMBL15699 0.71 F7 (0.56) EGFRSRCKDRF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965106-A ADMINISTERING TARGETING MOIETY COUPLED TO AFFINITY COMPONENT, WHEREIN TARGETING MOIETY HAS AFFINITY FOR BINDING SITES IN TARGET AREA, AND BINDING PARTNER TO AFFINITY COMPONENT COUPLED TO FUNCTIONAL MOIETY TO LOCALIZE FUNCTIONAL MOIETY IN TARGET PERIMMUNE HOLDINGS, INC. (US) 1999-10-12 — — US disclosed
Send feedback